Assessment of reactive metabolites in drug-induced liver injury

Cited 11 time in scopus
Metadata Downloads
Assessment of reactive metabolites in drug-induced liver injury
K S Lee; Soo Jin Oh; H M Kim; K H Lee; S K Kim
Bibliographic Citation
Archives of Pharmacal Research, vol. 34, no. 11, pp. 1879-1886
Publication Year
The aim of the current review is to summarize present methods used for the determination of reactive metabolites, which can predict drug-induced liver injury (DILI) in drug discovery and development. DILI is one of the most frequent reasons for the withdrawal of an approved drug from the market, and it accounts for up to 50% of acute liver failure cases. This review is structured into three sections. The first section is a general overview of the relationship between drug metabolism and liver injury. The second section introduces in vitro methods for the assessment of reactive metabolites for drug discovery and development. In the third section, limitations and future directions for the development of methods for predicting DILI are described.
Acyl glucuronideDrug metabolismDrug-induced liver injuryMechanism-based inhibitionReactive metabolites
Pharmaceutical Soc Korea
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.